Inflammation, Lipids, and Limb Risk: New Clues from Two Cohorts #ActAgainstAmputation #PAD #VascularDisease #CLTI


Peripheral artery disease (PAD) is one of the most devastating complications of diabetes—contributing to ischemic pain, functional decline, and, in severe cases, amputation. Despite its prevalence, early detection remains elusive, and clinicians continue to search for simple, reliable markers of risk.

A new multicohort study led by Wang and colleagues now shines a spotlight on a set of easily measured blood markers—lipid metabolism-related inflammatory indices (LMIIs)—that may help flag patients at higher risk for PAD .


The Study at a Glance

  • Who was studied?
    • 2,837 older adults with type 2 diabetes (≥60 years) from the Jinshan Cohort in China.
    • 13,542 participants with type 2 diabetes from the UK Biobank.
  • What are LMIIs?
    • NHR – neutrophil-to-HDL ratio
    • MHR – monocyte-to-HDL ratio
    • PHR – platelet-to-HDL ratio
    • LHR – lymphocyte-to-HDL ratio These composite indices integrate inflammation (immune cell counts) with lipid metabolism (HDL cholesterol), both central in atherosclerosis biology.
  • How were outcomes assessed?
    • PAD was diagnosed using ankle-brachial index and arterial pulse assessments in China, and health record codes in the UK Biobank.

Key Findings

  • Higher levels of all four LMIIs were associated with greater PAD risk.
    • In China, the odds of PAD increased by 24–69% per unit rise in these indices.
    • In the UK, hazard ratios showed more modest but consistent elevations, with risk increasing 3–19% per unit rise.
  • Population differences mattered.
    • Risks were more pronounced in women, urban residents, smokers, and those with HbA1c ≥7%.
    • Aspirin use and glycemic status modified some associations in the UK Biobank.
  • Kidney function played a role.
    • eGFR (estimated glomerular filtration rate) mediated ~10–20% of the relationship between LMIIs and PAD—linking systemic inflammation, metabolic stress, and vascular disease .

Why This Matters

For years, inflammation and dyslipidemia have been recognized as intertwined drivers of atherosclerosis. This study offers:

  • Practical markers: LMIIs can be calculated from routine lab tests (CBC + HDL-C).
  • Stratified insights: Identifying vulnerable subgroups (e.g., women with poorly controlled diabetes) could refine preventive strategies.
  • Mechanistic links: The mediation by kidney function highlights how systemic metabolic stressors interconnect in PAD pathogenesis.

Looking Ahead

While promising, these results should be validated in more diverse populations and across longer follow-up periods. Still, the concept is compelling: a simple blood draw may one day help us identify diabetic patients at greatest risk of limb loss—early enough to intervene.

Citation:

Wang Y, Jiang Q, Li X, Ren B, Li B, Li H, Fang Y, Dong Z, Huang L. Lipid metabolism-related inflammatory indices and incident peripheral artery disease in type 2 diabetes: a multicohort study from China and the UK Biobank. Cardiovasc Diabetol. 2025;24:346. doi:10.1186/s12933-025-02887-2 .


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Up ↑

Discover more from DF Blog

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights